持续气道正压通气对妊娠期阻塞性睡眠呼吸暂停综合征孕妇母儿结局的影响
回顾性分析北京大学人民医院2021年1月至2024年5月180例妊娠期阻塞性睡眠呼吸暂停综合征(OSAS)孕妇,按是否接受持续气道正压通气(CPAP)规范化治疗分为CPAP组42例和对照组138例。CPAP组分娩孕周更晚、小于胎龄儿比例更低、新生儿出生体重更大、胎盘重量及胎盘重量/新生儿出生体重比更低;中重度OSAS孕妇中CPAP组妊娠期高血压疾病发生率低于对照组。
要点
- CPAP组分娩孕周晚于对照组,小于胎龄儿比例低于对照组,新生儿出生体重高于对照组。
- CPAP组胎盘重量及胎盘重量/新生儿出生体重比均低于对照组。
- 中重度OSAS孕妇中CPAP组妊娠期高血压疾病发生率低于对照组。
核心结论
- CPAP治疗可延长OSAS孕妇的分娩孕周,降低小于胎龄儿发生率,增加新生儿出生体重,并降低中重度OSAS孕妇妊娠期高血压疾病发生率,值得在临床推广。
- CPAP治疗改善新生儿结局与胎盘密切相关,值得进一步探究。
研究设计与样本
- 回顾性分析2021年1月至2024年5月在北京大学人民医院因OSAS高危因素行妊娠期睡眠监测确诊OSAS的孕妇180例。
- 根据是否接受CPAP规范化治疗分为CPAP组42例和对照组138例,CPAP组中重度OSAS孕妇9例,对照组中重度OSAS孕妇34例。
主要发现
- CPAP组分娩孕周晚于对照组[(38.7±1.0)vs(38.0±1.4)周],小于胎龄儿比例低于对照组[0(0/42)vs 12.3%(17/138)],新生儿出生体重大于对照组[(3 396±475)vs(3 082±710)g],差异均有统计学意义(P均<0.05)。
- CPAP组与对照组分娩方式、早产和产后出血发生率、脐动脉血气分析pH<7.1、乳酸≥6.0 mmol/L、碱剩余<-12.0 mmol/L占比、妊娠期糖尿病及妊娠期高血压疾病发生率比较,差异均无统计学意义(P均>0.05)。
- CPAP组胎盘重量小于对照组[(554.0±70.6)vs(615.7±119.1)g],胎盘重量/新生儿出生体重比小于对照组(中位数0.17 vs 0.19),差异均有统计学意义(P均<0.05)。
- CPAP组中重度OSAS孕妇妊娠期高血压疾病发生率低于对照组[1/9 vs 61.8%(21/34)],差异有统计学意义(P<0.05)。
临床怎么用
- 作者认为CPAP治疗值得在临床推广。
- 作者认为CPAP治疗改善新生儿结局与胎盘密切相关,值得进一步探究。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To analyze the effect of continuous positive airway pressure (CPAP) on maternal and neonatal outcomes in pregnant women with obstructive sleep apnea syndrome (OSAS), especially on the incidence of hypertensive disorder in pregnancy (HDP) in women with moderate to severe OSAS. Methods: A total of 180 pregnant women with OSAS who were diagnosed through sleep monitoring during pregnancy due to high-risk factors of OSAS and registered in Peking University People's Hospital from January 2021 to May 2024 were selected as the study subjects. Clinical data were collected from medical records for retrospective analysis. According to whether they received standardized treatment with CPAP, they were divided into the CPAP treatment group (42 cases) and the control group (138 cases). The CPAP treatment group consisted of 9 pregnant women with moderate to severe OSAS, while the control group consisted of 34 pregnant women with moderate to severe OSAS. The maternal and neonatal outcomes, the incidence of HDP, placental weight after delivery and placental weight/neonatal birth weight ratio were compared between the two groups. Results: (1) The average gestational age of pregnant women in the CPAP treatment group was higher than that in the control group [(38.7±1.0) vs (38.0±1.4) weeks], the proportion of infants small for gestational age (SGA) in the CPAP treatment group was lower [0 (0/42) vs 12.3% (17/138)], and the birth weight of infants in the CPAP treatment group was bigger [(3 396±475) vs (3 082±710) g); the differences between the two groups were statistically significant (all P<0.05). There were no significant differences between the CPAP treatment group and the control group in terms of delivery mode, rates of postpartum hemorrhage and preterm birth, umbilical artery blood gas analysis pH<7.1, lactate≥6.0 mmol/L, base excess<-12.0 mmol/L and the incidence of gestational diabetes mellitus and HDP (all P>0.05). (2) The placental weight of the CPAP treatment group was significantly lower than that of the control group [(554.0±70.6) vs (615.7±119.1) g], the placental weight/newborn birth weight ratio of the CPAP treatment group was significantly lower than that of the control group (median: 0.17 vs 0.19), and the differences were statistically significant (all P<0.05). (3) The incidence of HDP in pregnant women with moderate to severe OSAS in the CPAP treatment group was lower than that in the control group [1/9 vs 61.8% (21/34)], and the difference was statistically significant (P<0.05). Conclusions: CPAP treatment could prolong the gestational age in pregnant women with OSAS, reduce the incidence of SGA, increase the birth weight of infants, and reduce the incidence of HDP in pregnant women with moderate to severe OSAS, and is worth promoting in clinical practice. The improvement of neonatal outcomes by CPAP treatment is closely related to the placenta, which is worthy of further exploration. 目的: 分析持续气道正压通气(CPAP)对阻塞性睡眠呼吸暂停综合征(OSAS)孕妇母儿结局的影响,尤其是对中重度OSAS孕妇妊娠期高血压疾病(HDP)发生的影响。 方法: 选取2021年1月至2024年5月在北京大学人民医院进行产前检查,因OSAS高危因素行妊娠期睡眠监测确诊OSAS的孕妇180例进行回顾性分析。根据是否接受CPAP规范化治疗,分为CPAP组(42例)和对照组(138例),CPAP组中重度OSAS孕妇9例,对照组中重度OSAS孕妇34例。对两组孕妇的母儿结局,特别是HDP发生率及孕妇分娩后胎盘重量、胎盘重量/新生儿出生体重比进行比较。 结果: (1)CPAP组孕妇的分娩孕周晚于对照组[分别为(38.7±1.0)、(38.0±1.4)周],CPAP组小于胎龄儿(SGA)比例低于对照组[分别为0(0/42)、12.3%(17/138)],新生儿出生体重大于对照组[分别为(3 396±475)、(3 082±710)g],差异均有统计学意义(P均<0.05)。CPAP组与对照组孕妇的分娩方式、早产和产后出血发生率、脐动脉血气分析pH<7.1、乳酸≥6.0 mmol/L、碱剩余<-12.0 mmol/L占比、妊娠期糖尿病及HDP发生率分别比较,差异均无统计学意义(P均>0.05)。(2)CPAP组的胎盘重量小于对照组[(554.0±70.6)、(615.7±119.1)g],胎盘重量/新生儿出生体重比小于对照组(中位数分别为0.17、0.19),分别比较,差异均有统计学意义(P均<0.05)。(3)CPAP组的中重度OSAS孕妇HDP发生率小于对照组[分别为1/9、61.8%(21/34)],两组比较,差异有统计学意义(P<0.05)。 结论: CPAP治疗可以延长OSAS孕妇的分娩孕周,降低SGA的发生率,增加新生儿出生体重,同时显著降低中重度OSAS孕妇HDP的发生率,值得在临床推广。CPAP治疗改善新生儿结局与胎盘密切相关,值得进一步探究。.
引用
- Tu ZL, Bai R, Zhang LY, et al. [Effects of continuous positive airway pressure on maternal and neonatal outcomes in pregnant women with obstructive sleep apnea syndrome]. Zhonghua Fu Chan Ke Za Zhi. 2025. PMID: 40159041. doi:10.3760/cma.j.cn112141-20240808-00444
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。